Cargando…
Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.
Cytotoxic antibodies to antigens specific for leukaemic myeloblasts have been sought in the serum of patients with acute myeloblastic leukaemia treated by immunotherapy with irradiated allogeneic myeloblasts and BCG. Assays of complement- and K-cell-mediated activity were used. Cytotoxicity to allog...
Autores principales: | Gale, D. G., MacLennan, I. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1977
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025282/ https://www.ncbi.nlm.nih.gov/pubmed/265730 |
Ejemplares similares
-
Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.
por: Tupchong, L., et al.
Publicado: (1978) -
Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
por: Taylor, G. M., et al.
Publicado: (1975) -
Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
por: Sonis, S. T., et al.
Publicado: (1977) -
A Case of Acute Myeloblastic Leukæmia
por: Fleming, Robert A., et al.
Publicado: (1924) -
Granulocyte function in myeloblastic leukaemia.
por: Wilkinson, P. M., et al.
Publicado: (1975)